Randomized Study for Efficacy and Safety of Ranibizumab 0.5mg in Treat-extend and Monthly Regimens in Patients With nAMD
Clinical trial NCT01948830 · COMPLETED
Trial details
- NCT number
- NCT01948830
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-17
- Primary completion
- 2015-11-19
- Enrollment
- 650
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.